Library

Ganciclovir

Athanor · official

C9H13N5O4 · 255.23 g/mol

IUPAC name: 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one

Also called Cytovene, CMV

Open in Athanor
The structure of Ganciclovir
Drawn from its SMILES with RDKit
Health hazardDangerMay damage fertility or the unborn child

Names and identifiers

IUPAC name
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one
Synonyms
Cytovene, CMV, Gancyclovir
+ 37 more

Vitrasert, Zirgan, BW-759U, Ganciclovirum, RS-21592, BW 759U, Cymevene, Virgan, Cymevan, 2'-Nor-2'-deoxyguanosine, 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine, DTXSID8041032, P9G3CKZ4P5, 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine, NSC-759656, 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one, 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one, CHEBI:465284, 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, DTXCID6021032, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol, 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one, 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one, 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone, 9-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine, Nordeoxyguanosine, NSC716361, Ganzyk-rtu, 2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-6,9-dihydro-3H-purin-6-one, RefChem:922069, 2'NDG, Ganciclovir, Monosodium Salt, J05AB06

Molecular formula
C9H13N5O4
Empirical formula
C9H13N5O4
Molecular weight
255.23 g/mol
Exact mass
255.09675
CAS number
82410-32-0
PubChem CID
135398740
Canonical SMILES
C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N
Isomeric SMILES
C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N
InChI
InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)
InChIKey
IRSCQMHQWWYFCW-UHFFFAOYSA-N
Molfile

Names, InChI and the identifiers from PubChem, retrieved 2026-10-14.

Physical properties

Appearance
White to off-white solid[1]
Solubility in water
Aqueous solubility of the drug is relatively constant over a pH range of 3.5-8.5 but increases substantially in strongly acidic or basic solutions.[1]
2 values

From Hazardous Substances Data Bank (HSDB), the most authoritative source here.

ValueAs writtenSource
–Ganciclovir sodium sterile powder occurs as a white to off-white, crystalline, lyophilized powder. Ganciclovir sodium has a solubility of 3 mg/mL in water at 25 °C and neutral pH. Both ganciclovir base and ganciclovir sodium are freely soluble in water at high pH (around 11). At more neutral pH, solubility is reduced, and crystallization may occur in concentrated solutions of the drug (exceeding 10 mg/ml). Ganciclovir sodium contains approximately 4 mEq of sodium per gram of ganciclovir. Following reconstitution with sterile water for injection, ganciclovir sodium solutions containing 50 mg of[1] Hazardous Substances Data Bank (HSDB)cites McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 93. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1993 (Plus Supplements, 1993)., p. 386
–shownAqueous solubility of the drug is relatively constant over a pH range of 3.5-8.5 but increases substantially in strongly acidic or basic solutions.[1] Hazardous Substances Data Bank (HSDB)cites McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 93. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1993 (Plus Supplements, 1993)., p. 386
log P
log Kow = -1.66[1]
pKa
pKa1 2.2[1]
2 values

Only one source reports it.

ValueAs writtenSource
–shownpKa1 2.2[1] Hazardous Substances Data Bank (HSDB)cites McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 93. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1993 (Plus Supplements, 1993)., p. 386
–pKa2 9.4[1] Hazardous Substances Data Bank (HSDB)cites McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 93. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1993 (Plus Supplements, 1993)., p. 386

Each value as its source reports it, with the source's number after it (listed under References). Where several sources report a property, the row shows the value most of them agree on, the rule the app uses; open the values to see every one.

Calculated

Heavy atoms
18
Rings
2
Aromatic rings
2
Fraction sp³ carbons (Fsp3)
0.44
H-bond donors
4
H-bond acceptors
7 computed here · PubChem 6
Rotatable bonds
5
TPSA (Ų)
139.3 computed here · PubChem 135
Formal charge
0
XLogP3
-2.5 PubChem
Complexity
346 PubChem
Stereocenters
None
Double-bond geometry
None specified
Point group
C1 of one 3D conformer with its hydrogens, by Athanor’s engine (as in the app)

Elemental analysis

  • C42.35%
  • H5.13%
  • N27.44%
  • O25.07%

Isotope pattern

100%255.09712%256.0991.5%257.101258.103

Each peak is a nominal mass with its abundance-weighted exact mass, as a percentage of the tallest, from IUPAC natural isotope abundances.

Computed from the structure with RDKit 2026.09 when this page was built, beside PubChem's own computed values from its record; where the two differ, both are shown.

Predicted

log P
-1.97 Crippen (Wildman and Crippen 1999)
log S (water solubility)
-0.22 ESOL (Delaney 2004), log mol/L
Synthetic accessibility
3 SA score, 1 easy to 10 hard (Ertl and Schuffenhauer 2009)

Drug-likeness: Lipinski’s rule of five

  • Molecular weight ≤ 500: 255.23
  • log P ≤ 5 (Crippen): -1.97
  • H-bond donors ≤ 5: 4
  • H-bond acceptors ≤ 10: 7

Passes all four rules.

¹³C NMR shifts, predicted

Predictions, not measurements; each names its method. A measured log P, where a source reports one, is under Physical properties.

Safety

Danger

Most widely reported: 46 company reports to ECHA. Source [2].

  • Health hazard
  • H360May damage fertility or the unborn child (93.5% of reports)

Precautionary statements: P203, P280, P318, P405, P501

Storage

  • Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 - 8 °C. Keep in a dry place.[1]
  • Ganciclovir capsules should be stored at 5-25 °C and ganciclovir sodium sterile powder should be stored at room temperature; exposure to temperatures exceeding 40 °C should be avoided.[1]

Safety data sheets on the supplier’s page: Selleck Chemicals, Vitas-M Laboratory, Alfa Chemistry.

Always read the supplier’s safety data sheet before working with it.

Spectra

Experimental spectra held by these sources; each link opens the source's own record.

Literature

Reading PubChem, OpenAlex and GSRS…

Bioactivity

Reading ChEMBL…

References

  1. [1]Hazardous Substances Data Bank (HSDB) · Public domain (US NLM) · via PubChem · retrieved 2026-10-14
  2. [2]European Chemicals Agency (ECHA) · ECHA legal notice: reuse with acknowledgement · via PubChem · retrieved 2026-10-14
  3. [3]SpectraBase · Linked only · via PubChem · retrieved 2026-10-14
  4. [4]Human Metabolome Database (HMDB) · Linked only · via PubChem · retrieved 2026-10-14
  5. [5]MassBank Europe · Linked only · via PubChem · retrieved 2026-10-14
  6. [6]MassBank of North America (MoNA) · CC BY 4.0 · via PubChem · retrieved 2026-10-14
  7. ·Calculated values: computed by Athanor with RDKit 2026.09 from the structure.
  8. ·Literature on PubChem

Data last updated 2026-10-14.